Delivering results in allergy, asthma and respiratory diseases.

Allergies affect millions of people worldwide, causing hundreds of thousands of deaths every year. With more than 40 clinical studies involving 5,000+ patients in this therapeutic area, we have a deep understanding of allergy, immunology and respiratory indications.

Seasonality, monotherapy, pediatric or adolescent populations are within the scope of our experienced teams including clinical operations, regulatory, medical, etc. From support with the protocol through feasibility to building regulatory, operational and patient engagement strategies, we can ensure you will make the most of the allergy season, allowing patients to receive better quality of life or even life-saving treatments.

Our teams have experience in allergic rhinitis, asthma, grass allergy, house dust mite allergy, birch pollen allergy and ragweed allergy.

We also have considerable experience in pulmonology, in particular in cystic fibrosis, chronic obstructive pulmonary disease (COPD) and pulmonary arterial hypertension (PAH). We have also worked in acute respiratory distress syndrome in COVID-19 patients. This experience allows us to quickly access the right investigators and patient pools to support clients’ trials in these indications.